Direct intracerebral injection of AQP4-IgG (without added complement) in rat brain has been shown to produce NMO-like pathology around the injection site, with loss of AQP4 and GFAP, deposition of activated complement, inflammation and demyelination [1]. This evidence concerns the gene GFAP and neuromyelitis optica.